Blood-Based RNA Signature May Predict Alzheimer’s Symptoms Years Before Onset
In a study involving nearly 2,400 participants, a 34-circular RNA signature outperformed plasma pTau217 in predicting progression to symptomatic Alzheimer's disease.
In a study involving nearly 2,400 participants, a 34-circular RNA signature outperformed plasma pTau217 in predicting progression to symptomatic Alzheimer's disease.
A study finds most UK direct-to-consumer health test vendors provide limited evidence of benefits and little information on risks, prompting calls for stronger oversight as the market is set to double by 2029.
Version 8.3 of the sample management platform targets inventory control and workflow efficiency for labs managing growing collections.
Clinisys will release CLS v2025.4 on Nov 24, adding AI-driven analytics, equipment maintenance tools, and expanded pre-configured content to streamline laboratory workflows and support faster implementation.
Israeli researchers report a blood test using epigenetic signatures in circulating nucleosomes can detect early-stage breast cancer and predict recurrence risk more accurately than tissue biopsies, according to a study in Nature.